Amber C Donahue

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Renal Cell Carcinoma

Long Non Coding Rna

Top Venues

Cancer discovery

Nature medicine

Pfizer Global Research and Development La Jolla

University of California CA-Irvine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Global Research and Development La Jolla Mar 30 2015

United States

Biomarker Clinical Assay Lead, Senior Manager :: Oncology Clinical Assay Group, Global Product Development

Quest Diagnostics Nichols Institute Mar 01 2010 - Feb 25 2015

United States

Senior Scientist :: Hematology/Oncology R&D

Quest Diagnostics Nichols Institute Jan 15 2007 - Mar 01 2010

United States

Scientist :: Hematology/Oncology R&D

Education History

University of California CA-Irvine Sep 01 2002 - Dec 08 2006

United States

PHD :: Molecular Biology & Biochemistry

Publications

Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery (2024)
Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery 14 (3) (2024)
Robert J Motzer, Paul B Robbins, Thomas Powles, Laurence Albiges, John B A G Haanen, James Larkin, Xinmeng Jasmine Mu, Keith A Ching, Motohide Uemura, Sumanta K Pal, Boris Alekseev, Gwenaelle Gravis, Matthew T Campbell, Konstantin Penkov, Jae Lyun Lee, Subramanian Hariharan, Xiao Wang, Weidong Zhang, Jing Wang, Aleksander Chudnovsky, Alessandra di Pietro, Amber C Donahue, Toni K Choueiri
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nature medicine 26 (11) (2020)